Green Thumb Industries (GTII) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
4 Aug, 2026Executive summary
Revenue for Q2 2026 reached $307 million, up 5% year-over-year, with normalized EBITDA of $84.3 million (27.5% margin).
Net income was $4.9 million ($0.02 per share), reversing a net loss of $0.6 million in Q2 2025.
Cash flow from operations was $29 million, and the company ended the quarter with $284 million in cash.
Share repurchases totaled 8 million shares in Q2 at just over $6/share; since Q4 2023, 29.5 million shares repurchased, returning over $200 million to shareholders.
Strategic focus remains on disciplined growth, capital returns, and readiness for regulatory changes, including federal rescheduling and potential uplisting.
Financial highlights
Retail revenue grew just under 4% year-over-year, with strong contributions from Minnesota, Connecticut, and Florida.
Same-store sales declined 1% on a base of 103 stores, a modest step down from Q1.
Gross profit was $138 million (45% margin), down from $146 million (50%) last year, mainly due to $17.5 million in brand licensing fees and price compression.
SG&A expenses rose to $118 million (38% of revenue), up from $107 million (36%) due to compensation and new store costs.
EBITDA was $53.1 million (17.3% margin), down from $69.1 million (23.6%) in Q2 2025.
Outlook and guidance
Q3 2026 revenue expected to be flat sequentially due to ongoing pricing pressures.
Full-year 2026 CapEx guidance remains at approximately $80 million.
Virginia adult-use market launch anticipated July 2027; company evaluating incremental investment.
Expects continued transition of consumers from hemp to regulated cannabis channels, especially in Ohio.
Management remains optimistic about long-term positioning due to scale, brands, and shelf space.
Latest events from Green Thumb Industries
- Market leader in THC with strong brands, financials, and growth from regulatory tailwinds.GTII
Investor presentation - All proposals passed, with strong financials and strategic focus on regulatory and brand growth.GTII
AGM 2026 - Cannabis market growth and brand leadership drive strong financial results and national expansion.GTII
Investor presentation - Cannabis market growth and brand leadership drive robust revenue and EBITDA performance.GTII
Investor presentation - Q1 2026 revenue up 7.5% to $300.2M, strong cash flow, and expanded share buybacks.GTII
Q1 2026 - Revenue rose 3.4% in 2025, with strong cash flow and retail expansion offset by margin pressure.GTII
Q4 2025 - Q2 revenue up 4.7% to $293.3M, but margins pressured by price compression and regulatory headwinds.GTII
Q2 2025 - Q3 revenue up 4% to $287M, Adjusted EBITDA margin 31.1%, strong cash flow and liquidity.GTII
Q3 2024 - Revenue up 1.4% to $280M, but net income and margins declined amid price compression.GTII
Q1 2025